Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 79,963,210
- Share change
- -16,368,791
- Total reported value
- $59,092,411
- Price per share
- $0.74
- Number of holders
- 29
- Value change
- +$9,527,080
- Number of buys
- 14
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
52%
|
73,114,592
|
$34,363,858 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
3/4/5
13F
|
10%+ Owner · Company |
8.1%
from 13F
|
68,394,000
|
$28,725,480 | — | 10 Apr 2025 | |
| Matthew Rizzo |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Michael Eggenberg |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
17,325,033
|
$10,552,677 | — | 15 Aug 2022 | |
| Altium Capital Management LLC |
13F
|
Company |
5.2%
|
7,252,998
|
$3,408,909 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.6%
|
2,251,512
|
$1,058,211 | — | 31 Mar 2025 | |
| Kevin D. Brandt |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
943,736
|
$566,242 | — | 15 Aug 2024 | |
| Robert McNamara |
3/4/5
|
Director |
—
class O/S missing
|
754,151
|
$452,491 | — | 15 Aug 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.51%
|
711,210
|
$334,269 | — | 31 Mar 2025 | |
| Jeffrey J. Peters |
3/4/5
|
Director |
—
class O/S missing
|
448,546
|
$273,209 | — | 15 Aug 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.39%
|
549,265
|
$258,225 | — | 31 Mar 2025 | |
| D. Mitchell Keller |
3/4/5
|
Director |
—
class O/S missing
|
353,124
|
$211,874 | — | 15 Aug 2024 | |
| Greg Jensen |
3/4/5
|
Vice President, Finance & CFO |
—
mixed-class rows
|
477,639
mixed-class rows
|
$173,795 | — | 15 Aug 2021 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.15%
|
212,024
|
$99,651 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.14%
|
189,100
|
$88,877 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.09%
|
120,326
|
$56,553 | — | 31 Mar 2025 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.08%
|
115,000
|
$54,050 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.08%
|
107,123
|
$50,348 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.07%
|
94,115
|
$44,234 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
58,666
|
$27,573 | — | 31 Mar 2025 | |
| Mink Brook Asset Management LLC |
13F
|
Company |
0.03%
|
48,469
|
$22,780 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.02%
|
31,266
|
$14,695 | — | 31 Mar 2025 | |
| Equitable Holdings, Inc. |
13F
|
Company |
0.02%
|
21,450
|
$10,082 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
21,475
|
$10,000 | — | 31 Mar 2025 | |
| Petros Family Wealth, LLC |
13F
|
Company |
0.01%
|
20,000
|
$9,400 | — | 31 Mar 2025 | |
| Baader Bank Aktiengesellschaft |
13F
|
Company |
0.01%
|
12,625
|
$4,736 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
5,869
|
$2,758 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
477
|
$224 | — | 31 Mar 2025 | |
| VALLEY WEALTH MANAGERS, INC. |
13F
|
Company |
0%
|
298
|
$140 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
102
|
$48 | — | 31 Mar 2025 | |
| Stonebridge Financial Group, LLC |
13F
|
Company |
0%
|
25
|
$12 | — | 31 Mar 2025 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
0%
|
12
|
$5 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
2
|
$1 | — | 31 Mar 2025 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q2 2025
As of 30 Jun 2025,
Xtant Medical Holdings, Inc. - Common Stock (XTNT) was held by
29 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,963,210 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, AWM Investment Company, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, Crescent Grove Advisors, LLC, MILLENNIUM MANAGEMENT LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, Private Advisor Group, LLC, and BlackRock, Inc..
This page lists
29
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
26
Q2 2025 holders
29
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.